Investigating the role of RIP kinases in inflammation and cell death related to type 2 diabetes
Official title: Novel roles for RIP kinases in islet inflammation and beta-cell cytotoxicity in type 2 diabetes
Funded at Rlr VA Medical Center · NIH-11053851 · Data updated 2026-11-12
This study is looking at how a protein called RIPK3 affects inflammation and the health of insulin-producing cells in people with type 2 diabetes, and it aims to see if a special treatment can help protect these cells from damage.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rlr VA Medical Center NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project start | October 1, 2024 |
| Project end | September 30, 2028 |
| Funding year | 2025 |
| NIH project number | 1I01BX006913-01 |
| Project ID | NIH-11053851 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with type 2 diabetes who are experiencing beta-cell dysfunction.
✕Less likely to help
Patients without type 2 diabetes or those with other forms of diabetes may not benefit from this research.
What this research studies
This research focuses on understanding how RIPK3, a protein involved in cell death, contributes to inflammation and the loss of insulin-producing beta cells in type 2 diabetes. By using a specialized mouse model, researchers will explore the mechanisms behind beta-cell dysfunction and how targeting RIPK3 with a small molecule inhibitor could potentially protect these cells. The study will involve advanced techniques such as RNA sequencing and live cell imaging to assess the effects of RIPK3 on inflammation and insulin secretion.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that protect beta cells and improve insulin function in patients with type 2 diabetes.
How similar studies have gone: Previous research has shown promising results in targeting RIPK3 for neurodegenerative diseases, suggesting potential for success in this novel approach for type 2 diabetes.
Where this research is happening
-
Rlr VA Medical Center
Indianapolis, United States Active
Researchers
- Principal investigator: Templin, Andrew T. — Rlr VA Medical Center
- Study coordinator: Templin, Andrew T.
Related research
Other NIH-funded projects on the same topics.
-
Subtyping Core for Research on the Causes of Type 2 Diabetes (SCORE-T2D)
A new U01 grant from a university research team aims to understand why Type 2 diabetes differs so much between people and how to tailor prevention and treatment.
-
Michigan Diabetes Project: A Peer-Led Self-Management Program for Adults with Type 2 Diabetes
A peer-led self-management program for adults with type 2 diabetes is being tested to see if it improves blood sugar control and daily diabetes care.
-
Alzheimer’s and dementia risk in people with prediabetes or type 2 diabetes
This grant aims to understand why some older adults with prediabetes or type 2 diabetes develop memory problems or dementia.
-
Personalized use of newer diabetes medicines for Type 2 diabetes
Aiming to tailor use of newer glucose-lowering drugs for people with type 2 diabetes to improve health and access in real-world settings.
-
Alzheimer’s and related dementia in older adults with prediabetes or type 2 diabetes
This grant aims to understand why cognitive problems occur in people 65 and older who have prediabetes or type 2 diabetes, using data from a long-running diabetes study to identify what drives memory and thinking decline.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.